ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "prevention"

  • Abstract Number: 1065 • ACR Convergence 2022

    Biosamples from VEDOSS Patients Show Pathological Signs of SSc: Opportunity for a Biololgical Diagnosis of Disease

    Rebecca Ross1, Emily Clarke1, Will Merchant1, Panji Mulipa1, Natalia Riobo-DelGaldo1 and Francesco Del Galdo2, 1University of Leeds, Leeds, United Kingdom, 2Leeds Institute of Rheumatic and Musculoskeletal Medicine, Faculty of Medicine and Health and NIHR Biomedical Research Centre, University of Leeds, Leeds, United Kingdom

    Background/Purpose: The VEDOSS study has recently indicated that more than 50% of patients affected by Raynaud’s phenomenon (RP) and specific SSc anti-nuclear antibodies (ANA) and/or…
  • Abstract Number: 2052 • ACR Convergence 2022

    Vaccine Uptake in Women with Systemic Lupus Erythematosus (SLE) in a Large Urban Teaching Hospital Serving a High-Risk Population

    J. Patricia Dhar1, Forsythe Hannah2, Louis Saravolatz3 and Susanna Szpunar4, 1Ascension St. John Hospital and Wayne State University School of Medicine, Bloomfield Hills, MI, 2Michigan Department of Human and Health Services, Lansing, MI, 3Ascension St John Hospital and Medical Center, Wayne State University School of Medicine (affiliate), Grosse Pointe Woods, MI, 4Ascension St. John Hospital, Grosse Pointe Woods, MI

    Background/Purpose: Infections are a major cause of morbidity & mortality in patients with systemic lupus erythematosus (SLE), including vaccine-preventable infections. SLE patients are considered to…
  • Abstract Number: 0185 • ACR Convergence 2022

    Empowered2work: Development and Delivery of a Multi-faceted Peer-coaching Workshop Focusing on Health Promotion and Ergonomic Issues in the Workplace

    Erika Mosor, Romualdo Ramos and Tanja Stamm, Medical University of Vienna, CeMSIIS - Center for Medical Statistics, Informatics, and Intelligent Systems, Section for Outcomes Research, Wien, Austria

    Background/Purpose: Work and education significantly impact health and quality of life in people with rheumatic and musculoskeletal diseases (RMDs). However, patients often experience internal and…
  • Abstract Number: 1194 • ACR Convergence 2022

    Key Self-reported Determinants of COVID-19 Vaccine Acceptance Among Persons with and Without Autoimmune Disease

    Jenny Gong1, Emma Barnboym2, megan O'Mara3, Natalie Gurevich3, Maya Mattar4, Donald Anthony5, Adam Perzynski2 and Nora Singer6, 1Case Western School of Medicine, Cleveland, OH, 2The MetroHealth System, Cleveland, OH, 3Cleveland Veteran Affairs Medical Center, Cleveland, OH, 4Louis Stokes VA Medical Center, Mayfield Heights, OH, 5Case, VA, Metro, Chardon, OH, 6The MetroHealth System at Case Western Reserve University School of Medicine, Cleveland, OH

    Background/Purpose: Patients with autoimmune disease are at increased risk for complications from SARS-CoV-2 infection. We aimed to compare patient perspectives on COVID-19 vaccination among persons…
  • Abstract Number: PP07 • ACR Convergence 2022

    Remissions and Vigilance

    Michael Scepaniak, Cockeysville, MD

    Background/Purpose: I've been diagnosed with spondyloarthritis (SpA) for a little more than 7 1/2 years. That diagnosis was preceded by roughly 9 months of significant…
  • Abstract Number: 0346 • ACR Convergence 2022

    Improving Eye Screening Compliance in Patients Taking Hydroxychloroquine in a Community Hospital Setting

    George Gennaoui1, Sana Kang2 and J. Patricia Dhar3, 1Ascension St. John Hospital, St. Clair Shores, MI, 2Ascension St John Hospital, Chesterfield, MO, 3Ascension St. John Hospital and Wayne State University School of Medicine, Bloomfield Hills, MI

    Background/Purpose: Hydroxychloroquine (HCQ) is a medication used in most patients with systematic lupus erythematous (SLE). It is generally a safe; however, it can cause retinal…
  • Abstract Number: 1200 • ACR Convergence 2022

    Vitamin D and Marine n-3 Fatty Acid Supplementation for Prevention of Autoimmune Disease in the VITAL Randomized Controlled Trial: Outcomes over 7 Years

    Karen Costenbader1, Nancy R Cook2, I-Min Lee2, Jill Hahn3, Joseph Walter1, Vadim Bubes1, Gregory Kotler1, Nicole Yang1, Sonia Friedman1, Erik K Alexander1 and JoAnn E Manson2, 1Brigham and Women's Hospital, Boston, MA, 2Harvard TH Chan School of Public Health, Brigham and Women's Hospital, Boston, MA, 3Brigham and Womens' Hospital, Boston, MA

    Background/Purpose: Strong biologic rationale supports potential effects of both vitamin D and of marine omega-3 (n3) fatty acids for autoimmune disease prevention. Within the randomized…
  • Abstract Number: 0477 • ACR Convergence 2022

    Can Beta-blockers Prevent Aortic Dilation in Patients with Giant Cell Arteritis and Large Vessel Vasculitis?

    Hubert De Boysson1, Anael DUMONT2, Samuel DESHAYES2, Alexandre Nguyen2 and Achille Aouba1, 1Department of Internal Medicine, UR4650 PSIR, Normandie Univ, UNICAEN, CHU de Caen Normandie, Caen, France, 2Caen University Hospital, Caen, France

    Background/Purpose: We analyzed whether the use of beta-blockers in addition to conventional care in patients with Giant cell arteritis (GCA) and large vessel vasculitis (LVV)…
  • Abstract Number: 1274 • ACR Convergence 2022

    Improving Pneumococcal Vaccination Rates Among Immunosuppressed Adults in an Academic Rheumatology Clinic Utilizing a Nurse Driven Protocol

    Elena Joerns1, Nagendra Pokala2, Dan Wang3, Joan Reisch3, Reuben Arasaratnam3, Bonnie Bermas1 and Puneet Bajaj3, 1UT Southwestern, Dallas, TX, 2University of Texas Southwestern Medical Center, Dallas, TX, 3UT Southwestern Medical Center, Dallas, TX

    Background/Purpose: Rheumatology patients are at risk for severe pneumococcal infections due to their underlying disease and immunosuppressive therapy. Current Advisory Committee on Immunization Practices guidelines…
  • Abstract Number: 0549 • ACR Convergence 2022

    Efficacy and Safety of the SARS-CoV-2 Vaccine in Patients with Rheumatoid Arthritis

    Esther Vicente-Rabaneda1, María Torres2, Miren Uriarte3, Patricia Quiroga-Colina3, Ainhoa Gutiérrez4, Ana Triguero5, Francisco Gutiérrez3, Noelia García3, Ana Romero-Robles3, Laura Cardeñoso4 and Santos Castañeda1, 1Division of Rheumatology, Hospital Universitario de La Princesa, IIS-Princesa, Madrid, Spain, 2Medical student, Hospital Universitario de La Princesa, Universidad Autónoma de Madrid, Madrid, Spain, 3Division of Rheumatology, Hospital Universitario de La Princesa, Madrid, Spain, 4Division of Microbiology, Hospital Universitario de La Princesa, Madrid, Spain, 5Hospital Universitario La Princesa, Madrid, Spain

    Background/Purpose: To describe the efficacy and safety of the SARS-CoV-2 vaccine in a series of patients with rheumatoid arthritis (RA).Methods: Retrospective observational study of RA…
  • Abstract Number: 1275 • ACR Convergence 2022

    Pneumococcal Vaccination Compliance Rate Among Lupus and Rheumatoid Arthritis Patients in Rheumatology Fellow’s Cllinic

    Sana Kang1, George Gennaoui2 and J. Patricia Dhar3, 1Ascension St John Hospital, Chesterfield, MO, 2Ascension St. John Hospital, St. Clair Shores, MI, 3Ascension St. John Hospital and Wayne State University School of Medicine, Bloomfield Hills, MI

    Background/Purpose: The US Center for Disease Control and Prevention recommends that adults ages 19 years and older, with immunocompromising conditions should receive a dose of…
  • Abstract Number: 0616 • ACR Convergence 2022

    Serum Proteomic Networks Associate with Pre-clinical Rheumatoid Arthritis Autoantibodies and Longitudinal Outcomes

    Liam O'Neil1, XIAOBO MENG1, Caitin McFadyen1, Marvin Fritzler2 and Hani El-Gabalawy1, 1University of Manitoba, Winnipeg, MB, Canada, 2University of Calgary, Calgary, AB, Canada

    Background/Purpose: The detection of anti-citrullinated protein antibodies (ACPA) is associated with increased risk for development of future Rheumatoid Arthritis (RA). The biological events that underpin…
  • Abstract Number: 1323 • ACR Convergence 2022

    Secondary Prevention of Vertebral Fractures Sustained Efficacy over Time

    JOSE ELOY OLLER RODRIGUEZ1, Elena Grau García2, Samuel Leal Rodriguez3, Laura Mas Sanchez2, Pablo Francisco Muñoz Martínez4, Carmen Riesco Bárcena5, Anderson Huaylla Quispe6, Cristobal Pavez Perales2, Francisco Miguel Ortiz Sanjuan7, José Ivorra Cortés2, Inés Cánovas Olmos2, Luis González Puig8, Isabel Martínez-Cordellat2, Carmen Nájera Herranz7, Rosa Negueroles Albuixech2, Elvira Vicens Bernabeu7, Alba Torrat Novés5, Daniel Ramos Castro2 and José andrés Román ivorra3, 1Hospital Universitario de La Fe, València, Spain, 2Rheumatology Department. Hospital Universitario y Politécnico La Fe, València, Spain, 3Hospital Universitari i Politécnic La Fe, València, Spain, 4Hospital Universitario y Politécnico La Fe, València, Spain, 5Rheumatology Department. Hospital Universitario y Politécnico La Fe, València, 6Medicina, València, Spain, 7Hospital Universitario de La Fe, València, 8Rheumatology Department. Hospital Universitario y Politécnico La Fe, Torrente, Valencia, Spain

    Background/Purpose: Vertebral fractures entail a notorious social and health problem, and their presence is the greatest risk factor for the appearance of a new vertebral…
  • Abstract Number: 0703 • ACR Convergence 2022

    Vaccination Against SARS-CoV2 in Patients with Systemic Autoimmune Diseases: A Safety Report from EULAR COVAX Registry

    Jose A Gomez-Puerta1, Ana Lúcia Martins Fernandes2, Juan Camilo Sarmiento-Monroy1, Saskia Lawson-Tovey3, Kimme Hyrich4, Laure Gossec5, Loreto Carmona6, Anja Strangfeld7, Elsa Mateus8, Ana Maria Rodrigues9, Eric Hachulla10, Marta Mosca11, Patrick Durez12, Bernd Raffeiner13, Nicolas Roux14, Viellard Eric15, Olivier Brocq16, Julija Zepa17, Eva Strakova18, Inita Bulina19, Vanda Mlynarikova20, Emoke Šteňová21, Martin Soubrier22, Xavier Mariette23 and Pedro Machado24, 1Hospital Clínic de Barcelona, Barcelona, Spain, 2Centro Hospitalar Universitário do Algarve, Faro, Portugal, 3Centre for Genetics and Genomics Versus Arthritis, Centre for Musculoskeletal Research, the University of Manchester, Manchester, UK AND National Institute of Health Research Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom, 4The University of Manchester, Manchester, United Kingdom, 5Sorbonne Université, Paris, France, 6Instituto de Salud Musculoesquelética (InMusc), Madrid, Spain, 7Deutsches Rheuma-Forschungszentrum Berlin, Berlin, Germany, 8EULAR, Lisboa, Portugal, 9Reuma.pt, Sociedade Portuguesa de Reumatologia, Lisbon, Portugal, 10University of Lille, LILLE, France, 11Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy, 12Rheumatology, Cliniques Universitaires Saint-Luc – Université catholique de Louvain (UCLouvain) – Institut de Recherche Expérimentale et Clinique (IREC), Brussels, Belgium, 13Department of Rheumatology, Central Hospital of Bolzano, Bolzano, Italy, 14Service de Rhumatologie, Hôpital Robert Schuman, Metz, France, 15Private practice, St. Malo, France, 16Rheumatology- CH Princesse Grace, Monaco, Monaco, 17Riga Stradins University, Latvia, Pauls Stradins Clinical University Hospital, Centre of Rheumatology, Riga, Latvia, Riga, Latvia, 18Department of Internal Medicine, Faculty Hospital Prešov, Presov, Slovakia, 19Pauls Stradins Clinical University Hospital, Riga, Riga, Latvia, 20National Institute of Rheumatic Diseases, Piešťany, Slovakia, 21University Hospital, Bratislava, Slovakia, 22Gabriel-Montpied Hospital, Clermont-Ferrand, France, 23Paris-Saclay University, Rueil Malmaison, Ile-de-France, France, 24University College London, London, United Kingdom

    Background/Purpose: Some concerns have been raised with the use of vaccines against SARS-CoV-2 in patients with Systemic Autoimmune Diseases (SAD) including the risk of serious…
  • Abstract Number: 1391 • ACR Convergence 2022

    Inadequate Cardiovascular Disease Risk Screening and Preventative Treatment in Patients with Rheumatoid Arthritis

    Tooba Munawar1, Farzam Khokhar2 and Andras Perl3, 1SUNY Upstate Medical Unviersity, Jamesville, NY, 2SUNY Upstate Medical University, Syracuse, NY, 3SUNY, Syracuse, NY

    Background/Purpose: Rheumatoid arthritis (RA) is a chronic inflammatory disease. Patients with RA are at risk of accelerated cardiovascular disease (CVD). The purpose of this study…
  • « Previous Page
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 12
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology